Homosexuals report more problems with prostate cancer drug than heterosexuals
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.
Jun 22, 2011
2
0